Contact
searchSearch
HMP Global

Upper Tract Urothelial Cancer Topic Center

News
Analysis Maps Evolution of UTUC Cells
10/23/2024
Jolynn Tumolo
The molecular characteristics of primary and metastatic tumors in patients with upper tract urothelial carcinoma (UTUC) are mostly stable, suggesting that oncologists may be able to use analyses of primary tumor samples for molecular...
The molecular characteristics of primary and metastatic tumors in patients with upper tract urothelial carcinoma (UTUC) are mostly stable, suggesting that oncologists may be able to use analyses of primary tumor samples for molecular...
The molecular characteristics of...
10/23/2024
First Report Managed Care
News
Guideline Addresses Nonmetastatic Upper Tract Urothelial Carcinoma Management
10/10/2024
Lisa Kuhns, PhD, MD
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and...
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and...
An American Urological...
10/10/2024
First Report Managed Care
News
Treatment Combination Advances Metastatic Urothelial Cancer Care
09/23/2024
Jolynn Tumolo
Recent data has established enfortumab vedotin (EV) and pembrolizumab (P) as the preferred first-line (1L) treatment option for patients with metastatic urothelial cancer, according to an article in American Society of Clinical Oncology...
Recent data has established enfortumab vedotin (EV) and pembrolizumab (P) as the preferred first-line (1L) treatment option for patients with metastatic urothelial cancer, according to an article in American Society of Clinical Oncology...
Recent data has established...
09/23/2024
First Report Managed Care
News
Stereotactic Magnetic Resonance (MR)-Guided Radiotherapy Shows Promise for Inoperable Upper Tract Urothelial Carcinoma
09/03/2024
Lisa Kuhns, PhD, MD
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided...
09/03/2024
First Report Managed Care
News
Study Finds Gemcitabine-Docetaxel Combo Outperforms BCG in Treating High-Risk Bladder Cancer
08/23/2024
Lisa Kuhns, PhD, MD
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel...
08/23/2024
First Report Managed Care
News
Consensus and Divergence in International Guidelines for Upper Tract Urothelial Carcinoma Management
08/09/2024
Lisa Kuhns, PhD, MD
“In this study, we sought to systematically compare current international guidelines and recommendations and to identify both discrepancies and similarities regarding the management of UTUC,” wrote researchers.
“In this study, we sought to systematically compare current international guidelines and recommendations and to identify both discrepancies and similarities regarding the management of UTUC,” wrote researchers.
“In this study, we sought to...
08/09/2024
First Report Managed Care
Formulary Frontlines®
Challenges, Treatment Options, and Costs Linked With Upper Tract Urothelial Carcinoma
06/20/2023
Julie Gould
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth...
06/20/2023
First Report Managed Care
Conference Coverage
Significant Financial Burden Associated With First-Line Urothelial Carcinoma Therapy
04/11/2023
Hannah Musick
More than half of Medicare members with urothelial carcinoma who received first-line systemic therapy experienced an adverse event, researchers found.
More than half of Medicare members with urothelial carcinoma who received first-line systemic therapy experienced an adverse event, researchers found.
More than half of Medicare...
04/11/2023
First Report Managed Care
Literature Review
Bladder Cancers: What is Low-Grade Upper Tract Urothelial Carcinoma?
09/16/2022
Edan Stanley
This literature review explores key data related to the epidemiology, clinical presentation, and treatment considerations for patients with low-grade upper tract urothelial carcinoma.
This literature review explores key data related to the epidemiology, clinical presentation, and treatment considerations for patients with low-grade upper tract urothelial carcinoma.
This literature review explores...
09/16/2022
First Report Managed Care
Online Exclusive
Examining the FDA’s Drug Approvals Process
07/14/2021
Dean Celia
The agency’s request for a review of the approvals process for the monoclonal antibody aducanumab is the latest twist in an unprecedented saga involving the Alzheimer disease treatment. We asked a panel of experts to analyze the approvals...
The agency’s request for a review of the approvals process for the monoclonal antibody aducanumab is the latest twist in an unprecedented saga involving the Alzheimer disease treatment. We asked a panel of experts to analyze the approvals...
The agency’s request for a...
07/14/2021
First Report Managed Care
Industry Insights
News

Current Issue

Oct/Nov/Dec Volume 22, Issue 4, First Report Managed Care
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use